Literature DB >> 26579605

Designing peptide sequences in flexible chain conformations to bind RNA: a search algorithm combining Monte Carlo, self-consistent mean field and concerted rotation techniques.

Xingqing Xiao1, Paul F Agris2, Carol K Hall1.   

Abstract

A search algorithm combining Monte Carlo, self-consistent mean field, and concerted rotation techniques was developed to discover peptide sequences that are reasonable HIV drug candidates due to their exceptional binding to human tRNAUUU(Lys3), the primer of HIV replication. The search algorithm allows for iteration between sequence mutations and conformation changes during sequence evolution. Searches conducted for different classes of peptides identified several potential peptide candidates. Analysis of the energy revealed that the asparagine and cysteine at residues 11 and 12 play important roles in "recognizing" tRNA(Lys3) via van der Waals interactions, contributing to binding specificity. Arginines preferentially attract the phosphate linkage via charge-charge interaction, contributing to binding affinity. Evaluation of the RNA/peptide complex's structure revealed that adding conformation changes to the search algorithm yields peptides with better binding affinity and specificity to tRNA(Lys3) than a previous mutation-only algorithm.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26579605     DOI: 10.1021/ct5008247

Source DB:  PubMed          Journal:  J Chem Theory Comput        ISSN: 1549-9618            Impact factor:   6.006


  2 in total

1.  Simulation study of the ability of a computationally-designed peptide to recognize target tRNALys3 and other decoy tRNAs.

Authors:  Xingqing Xiao; Binwu Zhao; Paul F Agris; Carol K Hall
Journal:  Protein Sci       Date:  2016-10-07       Impact factor: 6.725

2.  De novo design of peptides that coassemble into β sheet-based nanofibrils.

Authors:  Xingqing Xiao; Yiming Wang; Dillon T Seroski; Kong M Wong; Renjie Liu; Anant K Paravastu; Gregory A Hudalla; Carol K Hall
Journal:  Sci Adv       Date:  2021-09-03       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.